Insights into Molecular cancer therapy: NOS-2 suppresses the expression of RECK tumor suppressor via up regulation of its target gene, 28/February/2014, 9.05 am

A molecular link between circadian rhythm disruption and inflammatory diseases: miR-185 increases the expression of proinflammatory cytokines via down regulation of its target gene, 28/February/2014, 8.43 am
February 28, 2014
Insights into improving reprogramming efficiency of differentiated cells into iPS cells: Sodium butyrate (NaB), a small-molecule inhibitor of histone deacetylases (HDACs), suppresses NR2F2 via up regulation of its target gene, 28/February/2014, 9.19 am
February 28, 2014
Show all

National Science day special

*********

We wish every one a very happy National Science day. On this special occasion, we are happy to announce that ideas posted today (28/February/2014) will be available to the use of Scientists/Professors/Physicians/Researchers for free.

So, there will be no terms and conditions for the ideas posted today (28/February/2014). Each idea posted will be served first come, first served basis.Write to info@genomediscovery.org for more details about the ideas posted.

 

Dr L Boominathan PhD

Director, GBMD.

 

Noble Laureate in Medicine (1998) Prof. Dr Ferid (The University of Texas, Houston, Texas, USA) has suggested in a number of papers that inhibition of NOS2 (Nitric oxide synthase) may have a therapeutic value in a number of cancers.

In connection with this finding, Dr L Boominathan, Director-cum-chief scientist of GBMD, reports that: Molecular insights into Cancer therapy: NOS-2 suppresses the expression of  tumor suppressor RECK via up regulation of its target gene. This study provides mechanistic insights into how inhibition of NOS-2 may improve caner therapy.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

To citeBoominathan, Insights into Molecular cancer therapy: NOS-2 suppresses the expression of  RECK tumor suppressor via up regulation of its target gene, 28/February/2014, 9.05 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

 

Comments are closed.